PortalPublikationenProstate-Specific Membrane Antigen-Guided Surgery

Prostate-Specific Membrane Antigen-Guided Surgery

Standard

Prostate-Specific Membrane Antigen-Guided Surgery. / Maurer, Tobias; Graefen, Markus; van der Poel, Henk; Hamdy, Freddie; Briganti, Alberto; Eiber, Matthias; Wester, Hans-Jürgen; van Leeuwen, Fijs W B.

in: J NUCL MED, Jahrgang 61, Nr. 1, 01.2020, S. 6-12.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung

Harvard

Maurer, T, Graefen, M, van der Poel, H, Hamdy, F, Briganti, A, Eiber, M, Wester, H-J & van Leeuwen, FWB 2020, 'Prostate-Specific Membrane Antigen-Guided Surgery', J NUCL MED, Jg. 61, Nr. 1, S. 6-12. https://doi.org/10.2967/jnumed.119.232330

APA

Maurer, T., Graefen, M., van der Poel, H., Hamdy, F., Briganti, A., Eiber, M., Wester, H-J., & van Leeuwen, F. W. B. (2020). Prostate-Specific Membrane Antigen-Guided Surgery. J NUCL MED, 61(1), 6-12. https://doi.org/10.2967/jnumed.119.232330

Vancouver

Maurer T, Graefen M, van der Poel H, Hamdy F, Briganti A, Eiber M et al. Prostate-Specific Membrane Antigen-Guided Surgery. J NUCL MED. 2020 Jan;61(1):6-12. https://doi.org/10.2967/jnumed.119.232330

Bibtex

@article{b456e12414de4e2bb690ae7148217eb4,
title = "Prostate-Specific Membrane Antigen-Guided Surgery",
abstract = "Since its introduction to the diagnostic pathway for prostate cancer management, prostate-specific membrane antigen (PSMA)-ligand PET has demonstrated great potential. PSMA-ligand imaging is increasingly influencing therapeutic decision making, although its impact on patient outcomes still needs to be defined. One relatively new application, enabled through chemical and engineering efforts, is PSMA-guided surgery. This review highlights the potential of PSMA-guided surgery and discusses its implications in lymph node dissection in primary and recurrent prostate cancer.",
keywords = "Humans, Ligands, Lymph Node Excision, Lymphatic Metastasis, Male, Medical Oncology/trends, Neoplasm Recurrence, Local, Positron-Emission Tomography, Prostatic Neoplasms/immunology, Proteasome Endopeptidase Complex/analysis, Radiopharmaceuticals, Radiosurgery, Salvage Therapy, Surgery, Computer-Assisted, Technetium/chemistry, Urology/trends",
author = "Tobias Maurer and Markus Graefen and {van der Poel}, Henk and Freddie Hamdy and Alberto Briganti and Matthias Eiber and Hans-J{\"u}rgen Wester and {van Leeuwen}, {Fijs W B}",
note = "{\textcopyright} 2020 by the Society of Nuclear Medicine and Molecular Imaging.",
year = "2020",
month = jan,
doi = "10.2967/jnumed.119.232330",
language = "English",
volume = "61",
pages = "6--12",
journal = "J NUCL MED",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "1",

}

RIS

TY - JOUR

T1 - Prostate-Specific Membrane Antigen-Guided Surgery

AU - Maurer, Tobias

AU - Graefen, Markus

AU - van der Poel, Henk

AU - Hamdy, Freddie

AU - Briganti, Alberto

AU - Eiber, Matthias

AU - Wester, Hans-Jürgen

AU - van Leeuwen, Fijs W B

N1 - © 2020 by the Society of Nuclear Medicine and Molecular Imaging.

PY - 2020/1

Y1 - 2020/1

N2 - Since its introduction to the diagnostic pathway for prostate cancer management, prostate-specific membrane antigen (PSMA)-ligand PET has demonstrated great potential. PSMA-ligand imaging is increasingly influencing therapeutic decision making, although its impact on patient outcomes still needs to be defined. One relatively new application, enabled through chemical and engineering efforts, is PSMA-guided surgery. This review highlights the potential of PSMA-guided surgery and discusses its implications in lymph node dissection in primary and recurrent prostate cancer.

AB - Since its introduction to the diagnostic pathway for prostate cancer management, prostate-specific membrane antigen (PSMA)-ligand PET has demonstrated great potential. PSMA-ligand imaging is increasingly influencing therapeutic decision making, although its impact on patient outcomes still needs to be defined. One relatively new application, enabled through chemical and engineering efforts, is PSMA-guided surgery. This review highlights the potential of PSMA-guided surgery and discusses its implications in lymph node dissection in primary and recurrent prostate cancer.

KW - Humans

KW - Ligands

KW - Lymph Node Excision

KW - Lymphatic Metastasis

KW - Male

KW - Medical Oncology/trends

KW - Neoplasm Recurrence, Local

KW - Positron-Emission Tomography

KW - Prostatic Neoplasms/immunology

KW - Proteasome Endopeptidase Complex/analysis

KW - Radiopharmaceuticals

KW - Radiosurgery

KW - Salvage Therapy

KW - Surgery, Computer-Assisted

KW - Technetium/chemistry

KW - Urology/trends

U2 - 10.2967/jnumed.119.232330

DO - 10.2967/jnumed.119.232330

M3 - SCORING: Review article

C2 - 31732677

VL - 61

SP - 6

EP - 12

JO - J NUCL MED

JF - J NUCL MED

SN - 0161-5505

IS - 1

ER -